These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31836014)

  • 1. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake.
    Li L; Zhao H; Chen B; Fan Z; Li N; Yue J; Ye Q
    J Transl Med; 2019 Dec; 17(1):418. PubMed ID: 31836014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter.
    Xu X; Shi X; Chen Y; Zhou T; Wang J; Xu X; Chen L; Hu L; Shen X
    Metabolism; 2018 Aug; 85():126-138. PubMed ID: 29577938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
    Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
    Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
    Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
    Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
    [No Abstract]   [Full Text] [Related]  

  • 6. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
    Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
    Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.
    Dwivedi SK; Singh N; Kumari R; Mishra JS; Tripathi S; Banerjee P; Shah P; Kukshal V; Tyagi AM; Gaikwad AN; Chaturvedi RK; Mishra DP; Trivedi AK; Sanyal S; Chattopadhyay N; Ramachandran R; Siddiqi MI; Bandyopadhyay A; Arora A; Lundåsen T; Anakk SP; Moore DD; Sanyal S
    Mol Endocrinol; 2011 Jun; 25(6):922-32. PubMed ID: 21493670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
    J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
    Ma Y; Huang Y; Yan L; Gao M; Liu D
    Pharm Res; 2013 May; 30(5):1447-57. PubMed ID: 23371517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
    Zhao T; Wang J; He A; Wang S; Chen Y; Lu J; Lv J; Li S; Wang J; Qian M; Li H; Shen X
    Metabolism; 2021 Jun; 119():154771. PubMed ID: 33831422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney.
    Sasaki M; Sasako T; Kubota N; Sakurai Y; Takamoto I; Kubota T; Inagi R; Seki G; Goto M; Ueki K; Nangaku M; Jomori T; Kadowaki T
    Diabetes; 2017 Sep; 66(9):2339-2350. PubMed ID: 28630133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
    Aljaylani A; Fluitt M; Piselli A; Shepard BD; Tiwari S; Ecelbarger CM
    Cell Physiol Biochem; 2020 Jul; 54(4):682-695. PubMed ID: 32678535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
    Wang S; Yuan X; Lu D; Guo L; Wu B
    Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
    Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
    Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
    Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
    Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
    J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.